Identification of novel piRNAs in bladder cancer

Cancer Letters

Volumn 356, Issue 2, 2015, Pages 561-567

  Chu, Haiyan ^a   Hui, Gaoyun ^a   Yuan, Lin ^b   Shi, Danni ^a   Wang, Yubang ^a   Du, Mulong ^a   Zhong, Dongyan ^a   Ma, Lan ^a   Tong, Na ^a   Qin, Chao ^c   Yin, Changjun ^c   Zhang, Zhengdong ^a   Wang, Meilin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Bladder cancer; PiRNA profiles

Indexed keywords

LUCIFERASE; OX40 LIGAND; PIWI INTERACTING RNA; MESSENGER RNA; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CASE REPORT; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; PREDICTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; TNFSF4 GENE; WESTERN BLOTTING; BLADDER; BLADDER TUMOR; COMPARATIVE STUDY; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84919459410     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.10.004     Document Type: Article

References (45)

1. Kiriluk K.J., Prasad S.M., Patel A.R., Steinberg G.D., Smith N.D. Bladder cancer risk from occupational and environmental exposures. Urol. Oncol 2012, 30:199-211.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
4. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet 2009, 10:704-714.
5. Wang M., Chu H., Li P., Yuan L., Fu G., Ma L., et al. Genetic variants in miRNAs predict bladder cancer risk and recurrence. Cancer Res 2012, 72:6173-6182.
6. Klattenhoff C., Theurkauf W. Biogenesis and germline functions of piRNAs. Development 2008, 135:3-9.
7. Aravin A., Gaidatzis D., Pfeffer S., Lagos-Quintana M., Landgraf P., Iovino N., et al. A novel class of small RNAs bind to MILI protein in mouse testes. Nature 2006, 442:203-207.
8. Girard A., Sachidanandam R., Hannon G.J., Carmell M.A. A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature 2006, 442:199-202.
9. Grivna S.T., Beyret E., Wang Z., Lin H. A novel class of small RNAs in mouse spermatogenic cells. Genes Dev 2006, 20:1709-1714.
10. Horwich M.D., Li C., Matranga C., Vagin V., Farley G., Wang P., et al. The Drosophila RNA methyltransferase, DmHen1, modifies germline piRNAs and single-stranded siRNAs in RISC. Curr. Biol 2007, 17:1265-1272.
11. Houwing S., Kamminga L.M., Berezikov E., Cronembold D., Girard A., van den Elst H., et al. A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in zebrafish. Cell 2007, 129:69-82.
12. Kalmykova A.I., Klenov M.S., Gvozdev V.A. Argonaute protein PIWI controls mobilization of retrotransposons in the Drosophila male germline. Nucleic Acids Res 2005, 33:2052-2059.
13. Lee H.C., Gu W., Shirayama M., Youngman E., Conte D., Mello C.C. C. elegans piRNAs mediate the genome-wide surveillance of germline transcripts. Cell 2012, 150:78-87.
14. Brennecke J., Malone C.D., Aravin A.A., Sachidanandam R., Stark A., Hannon G.J. An epigenetic role for maternally inherited piRNAs in transposon silencing. Science 2008, 322:1387-1392.
15. Kuramochi-Miyagawa S., Watanabe T., Gotoh K., Totoki Y., Toyoda A., Ikawa M., et al. DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. Genes Dev 2008, 22:908-917.
16. Yin H., Lin H. An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster. Nature 2007, 450:304-308.
17. Rajasethupathy P., Antonov I., Sheridan R., Frey S., Sander C., Tuschl T., et al. A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity. Cell 2012, 149:693-707.
18. Ross R.J., Weiner M.M., Lin H. PIWI proteins and PIWI-interacting RNAs in the soma. Nature 2014, 505:353-359.
19. Lu Y., Li C., Zhang K., Sun H., Tao D., Liu Y., et al. Identification of piRNAs in Hela cells by massive parallel sequencing. BMB Rep 2010, 43:635-641.
20. Cheng J., Guo J.M., Xiao B.X., Miao Y., Jiang Z., Zhou H., et al. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin. Chim. Acta 2011, 412:1621-1625.
21. Cheng J., Deng H., Xiao B., Zhou H., Zhou F., Shen Z., et al. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett 2012, 315:12-17.
22. Huang G., Hu H., Xue X., Shen S., Gao E., Guo G., et al. Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer. Clin. Transl. Oncol 2012, 15:563-568.
23. Yan H., Wu Q.L., Sun C.Y., Ai L.S., Deng J., Zhang L., et al. piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma. Leukemia 2014, 10.1038/leu.2014.135.
24. Law P.T., Qin H., Ching A.K., Lai K.P., Co N.N., He M., et al. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma. J. Hepatol 2013, 58:1165-1173.
25. Lee E.J., Banerjee S., Zhou H., Jammalamadaka A., Arcila M., Manjunath B.S., et al. Identification of piRNAs in the central nervous system. RNA 2011, 17:1090-1099.
26. Rouget C., Papin C., Boureux A., Meunier A.C., Franco B., Robine N., et al. Maternal mRNA deadenylation and decay by the piRNA pathway in the early Drosophila embryo. Nature 2010, 467:1128-1132.
27. Smirnov D.A., Cheung V.G. ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs. Am. J. Hum. Genet 2008, 83:243-253.
28. Kirino Y., Mourelatos Z. 2'-O-methyl modification in mouse piRNAs and its methylase. Nucleic Acids Symp. Ser. (Oxf) 2007, 417-418.
29. Wang M., Zhang Z., Zhu H., Fu G., Wang S., Wu D., et al. A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population. Clin. Cancer Res 2008, 14:3633-3640.
30. Cox D.N., Chao A., Lin H. piwi encodes a nucleoplasmic factor whose activity modulates the number and division rate of germline stem cells. Development 2000, 127:503-514.
31. Carmell M.A., Girard A., van de Kant H.J., Bourc'his D., Bestor T.H., de Rooij D.G., et al. MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev. Cell 2007, 12:503-514.
32. Kuramochi-Miyagawa S., Kimura T., Ijiri T.W., Isobe T., Asada N., Fujita Y., et al. Mili, a mammalian member of piwi family gene, is essential for spermatogenesis. Development 2004, 131:839-849.
33. Taubert H., Greither T., Kaushal D., Wurl P., Bache M., Bartel F., et al. Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene 2007, 26:1098-1100.
34. Grochola L.F., Greither T., Taubert H., Moller P., Knippschild U., Udelnow A., et al. The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death. Br. J. Cancer 2008, 99:1083-1088.
35. Liu X., Sun Y., Guo J., Ma H., Li J., Dong B., et al. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int. J. Cancer 2006, 118:1922-1929.
36. Zeng Y., Qu L.K., Meng L., Liu C.Y., Dong B., Xing X.F., et al. HIWI expression profile in cancer cells and its prognostic value for patients with colorectal cancer. Chin. Med. J. (Engl.) 2011, 124:2144-2149.
37. Klattenhoff C., Bratu D.P., McGinnis-Schultz N., Koppetsch B.S., Cook H.A., Theurkauf W.E. Drosophila rasiRNA pathway mutations disrupt embryonic axis specification through activation of an ATR/Chk2 DNA damage response. Dev. Cell 2007, 12:45-55.
38. Chen Y., Pane A., Schupbach T. Cutoff and aubergine mutations result in retrotransposon upregulation and checkpoint activation in Drosophila. Curr. Biol 2007, 17:637-642.
39. Baum P.R., Gayle R.B., Ramsdell F., Srinivasan S., Sorensen R.A., Watson M.L., et al. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 1994, 13:3992-4001.
40. Ohshima Y., Tanaka Y., Tozawa H., Takahashi Y., Maliszewski C., Delespesse G. Expression and function of OX40 ligand on human dendritic cells. J. Immunol 1997, 159:3838-3848.
41. Croft M. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu. Rev. Immunol 2010, 28:57-78.
42. Gough M.J., Ruby C.E., Redmond W.L., Dhungel B., Brown A., Weinberg A.D. OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. Cancer Res 2008, 68:5206-5215.
43. Piconese S., Valzasina B., Colombo M.P. OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J. Exp. Med 2008, 205:825-839.
44. Redmond W.L., Weinberg A.D. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer. Crit. Rev. Immunol 2007, 27:415-436.
45. Buglio D., Khaskhely N.M., Voo K.S., Martinez-Valdez H., Liu Y.J., Younes A. HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma. Blood 2011, 117:2910-2917.